Roles > EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor
Page last updated: 2024-08-05 15:41:06
EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor
An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase).
ChEBI ID: 86501
Members (1)
| Member | Definition | Class |
|---|
| troleandomycin | A semi-synthetic macrolide antibiotic obtained by acetylation of the three free hydroxy groups of oleandomycin. Troleandomycin is only found in individuals that have taken the drug. | troleandomycin |
Research
Studies (508)
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|
| pre-1990 | 257 (50.59) | 18.7374 |
| 1990's | 140 (27.56) | 18.2507 |
| 2000's | 81 (15.94) | 29.6817 |
| 2010's | 28 (5.51) | 24.3611 |
| 2020's | 2 (0.39) | 2.80 |
Study Types
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|
| Trials | 26 (4.57%) | 5.53% |
| Reviews | 23 (4.04%) | 6.00% |
| Case Studies | 33 (5.80%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 487 (85.59%) | 84.16% |
Protein Targets (6)
Inhibition Measurements